{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-066366","form_type":"8-K","ticker":"QTTB","cik":"0001661998","company_name":"Q32 Bio Inc.","filed_at":"2025-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.249059+00:00","generated_at":"2026-05-22T04:42:55.199711+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Q32 Bio Q1 net loss $11.0M; cash $65.5M, runs into 2H'26; first patient dosed in Phase 2a Part B for AA","bullets":["Net loss $(11.0)M ($(0.90)/share) vs. net income $1.0M in Q1 2024; R&D expense $7.1M (down 28% YoY).","Cash and equivalents $65.5M as of March 31, 2025; expected to fund operations into 2H'26.","First patient dosed in SIGNAL-AA Phase 2a Part B; topline data expected 1H'26.","Fast Track designation granted to bempikibart for alopecia areata; durable responses seen in late-breaking AAD presentation.","First patient dosed in Part A open-label extension; median follow-up 41 weeks shows maintenance or further hair growth."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-066366","json":"https://secwatch.observer/filing/0000950170-25-066366.json","markdown":"https://secwatch.observer/filing/0000950170-25-066366.md","text":"https://secwatch.observer/filing/0000950170-25-066366.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661998/000095017025066366/0000950170-25-066366-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661998/000095017025066366/qttb-20250508.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T04:42:55.199711+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}